MEMarco L. Ernst

Marco L. Ernst

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marco L. Ernst has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    De novo design and evolution of an artificial metathase for cytoplasmic olefin metathesis

    by Zhi Zou, Indrek Kalvet, Boris Lozhkin, Elinor Morris, Kailin Zhang, Dongping Chen, Marco L. Ernst, Xiang Zhang, David Baker, Thomas R. Ward

    Artificial metalloenzymes present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Here we address these limitations by introducing an artificial metathase—an artificial metalloenzyme designed for ring-closing metathesis—for whole-cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo-designed protein. By combining computational design with genetic optimization, a binding affinity ( K D ≤ 0.2 μM) between the protein scaffold and cofactor is achieved through supramolecular anchoring. Directed evolution of the artificial metathase yielded variants exhibiting excellent catalytic performance (turnover number ≥1,000) and biocompatibility. This work represents a pronounced leap in the de novo design and in cellulo engineering of artificial metalloenzymes, paving the way for abiological catalysis in living systems.


  • Open Access

    De Novo Design and Evolution of an Artificial Metathase for Cytoplasmic Olefin Metathesis

    by Thomas Ward, Zhi Zou, Indrek Kalvet, Boris Lozhkin, Elinor Morris, Kailin Zhang, Dongping Chen, Marco Ernst, Xiang Zhang, David Baker

    Artificial metalloenzymes (ArMs) present a promising avenue for abiotic catalysis within living systems. However, their in vivo application is currently limited by critical challenges, particularly in selecting suitable protein scaffolds capable of binding abiotic cofactors and maintaining catalytic activity in complex media. Herein, we address these limitations by introducing an artificial metathase—an artificial metalloenzyme designed for ring-closing metathesis (RCM)— for whole cell biocatalysis. Our approach integrates a tailored metal cofactor into a hyper-stable, de novo designed protein. By combining computational design with genetic optimization, a binding affinity ( K D ≤ 0.2 μM) between the protein scaffold and cofactor is achieved through supramolecular anchoring. Directed evolution of the artificial metathase yielded variants exhibiting excellent catalytic performance (TON ≥ 1000) and biocompatibility. This work represents a pronounced leap in the de novo design and in vivo engineering of artificial metalloenzymes, paving the way for abiological catalysis in living systems.